SCHEMBL13203365

SCHEMBL13203365

CC(C)(c1ccc(Oc2ccc(N3COc4ccccc4C3)cc2)cc1)c1ccc(Oc2ccc(N3COc4ccccc4C3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.40
MAPT P10636 4/20 0.40
NPC1 O15118 3/20 0.40
TP53 P04637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
BACE1 P56817 1/20 0.40
LTA4H P09960 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 2/20 0.31
TSHR P16473 2/20 0.31
CYP1A2 P05177 1/20 0.31
PPARG P37231 1/20 0.31
HIF1A Q16665 1/20 0.31
LMNA P02545 2/20 0.31
VDR P11473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40426 0.92 RAB9A (0.38) RAB9AMAPTNPC1TP53ALDH1A1
SCHEMBL13823374 0.89 ALDH1A1 (0.38) RAB9AMAPTNPC1TP53ALDH1A1
SCHEMBL15202635 0.89 GAA (0.39) RAB9AMAPTNPC1TP53ALDH1A1
SCHEMBL13203360 0.89 NPC1 (0.44) RAB9AMAPTNPC1TP53ALDH1A1
SCHEMBL95039 0.89 NPC1 (0.44) RAB9AMAPTNPC1TP53ALDH1A1
SCHEMBL16640712 0.88 ALDH1A1 (0.36) RAB9AMAPTNPC1TP53ALDH1A1
SCHEMBL13933836 0.87 TSHR (0.40) RAB9AMAPTNPC1TP53ALDH1A1
SCHEMBL10002046 0.85 NPC1 (0.42) RAB9AMAPTNPC1TP53ALDH1A1
SCHEMBL15358724 0.85 NPC1 (0.41) RAB9AMAPTNPC1TP53ALDH1A1
SCHEMBL16644712 0.85 ALDH1A1 (0.35) RAB9AMAPTNPC1TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233811-B1 CURABLE BENZOXAZINE COMPOSITIONS WITH IMPROVED THERMAL STABILITY 3M INNOVATIVE PROPERTIES CO (US) 2020-09-09 EP disclosed
US-10224259-B2 Resin composition for sealing semiconductor and semiconductor device SUMITOMO BAKELITE CO., LTD. (JP) 2019-03-05 US disclosed
US-10023698-B2 Curable benzoxazine compositions with improved thermal stability 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-07-17 US disclosed
US-10023698-B2 Curable benzoxazine compositions with improved thermal stability 3M INNOVATIVE PROPERTIES COMPANY (US) 2018-07-17 US disclosed
US-20180127655-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC CORPORATION (JP) 2018-05-10 US disclosed
US-20180127655-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC CORPORATION (JP) 2018-05-10 US disclosed
US-9909065-B2 Liquid crystal aligning agents for forming photo-aligning liquid crystal alignment layers, liquid crystal alignment layers and liquid crystal display devices using the same JNC CORPORATION (JP) 2018-03-06 US disclosed
US-9909065-B2 Liquid crystal aligning agents for forming photo-aligning liquid crystal alignment layers, liquid crystal alignment layers and liquid crystal display devices using the same JNC CORPORATION (JP) 2018-03-06 US disclosed
US-20170327744-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC CORP (JP) 2017-11-16 US disclosed
US-20170327744-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC CORP (JP) 2017-11-16 US disclosed
US-20160372394-A1 RESIN COMPOSITION FOR SEALING SEMICONDUCTOR AND SEMICONDUCTOR DEVICE SUMITOMO BAKELITE CO., LTD. (JP) 2016-12-22 US disclosed
US-20160372394-A1 RESIN COMPOSITION FOR SEALING SEMICONDUCTOR AND SEMICONDUCTOR DEVICE SUMITOMO BAKELITE CO., LTD. (JP) 2016-12-22 US disclosed
WO-2016099988-A1 CURABLE BENZOXAZINE COMPOSITIONS WITH IMPROVED THERMAL STABILITY 3M INNOVATIVE PROPERTIES COMPANY (US) 2016-06-23 WO disclosed
US-20150119522-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC CORPORATION (JP) 2015-04-30 US disclosed
US-20150119522-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC CORPORATION (JP) 2015-04-30 US disclosed
US-20150105503-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC PETROCHEMICAL CORPORATION (JP) 2015-04-16 US disclosed
US-20150105503-A1 LIQUID CRYSTAL ALIGNING AGENTS FOR FORMING PHOTO-ALIGNING LIQUID CRYSTAL ALIGNMENT LAYERS, LIQUID CRYSTAL ALIGNMENT LAYERS AND LIQUID CRYSTAL DISPLAY DEVICES USING THE SAME JNC PETROCHEMICAL CORPORATION (JP) 2015-04-16 US disclosed
WO-2013161569-A1 LIQUID-CRYSTAL-ORIENTING AGENT FOR FORMING LIQUID-CRYSTAL-ORIENTED FILM FOR PHOTOALIGNMENT, LIQUID-CRYSTAL-ORIENTED FILM, AND LIQUID-CRYSTAL DISPLAY ELEMENT USING LIQUID-CRYSTAL-ORIENTED FILM JNC株式会社 (JP) 2013-10-31 WO disclosed
US-7781561-B2 Processes of synthesizing aromatic amine-based benzoxazine resins National Chungsing University (TW) 2010-08-24 US disclosed
US-20080045688-A1 Processes of synthesizing aromatic amine-based benzoxazine resins NATIONAL CHUNGHSING UNIVERSITY 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023698-B2 Curable benzoxazine compositions with improved thermal stability BRWD1, CBX7, WIZ RAB9A 4384/4885MAPT 499/4885NPC1 4224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.